Cargando…
Qingxin Kaiqiao Fang Inhibits Aβ(25-35)-Induced Apoptosis in Primary Cultured Rat Hippocampal Neuronal Cells via the p38 MAPK Pathway: An Experimental Validation and Network Pharmacology Study
Qingxin kaiqiao fang (QKF), a traditional Chinese medicine compound, has been applied to treat Alzheimer's disease (AD) for many years and has exhibited remarkable effects. However, the underlying mechanism is still not explicit. The current study aims to investigate whether QKF exerts an antia...
Autores principales: | Wang, Tian-Qi, Lai, Xiao-Xiao, Xu, Lu-Ting, Shen, Yan, Lin, Jian-Wei, Gao, Shi-Yu, Hu, Hai-Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424524/ https://www.ncbi.nlm.nih.gov/pubmed/32831882 http://dx.doi.org/10.1155/2020/9058135 |
Ejemplares similares
-
Qingxin kaiqiao fang ameliorates memory impairment and inhibits apoptosis in APP/PS1 double transgenic mice through the MAPK pathway
por: Gao, Shiyu, et al.
Publicado: (2019) -
Effect of Qingxin Kaiqiao Fang on Hippocampus mRNA Expression of the Inflammation-Related Genes IL-1β, GFAP, and Aβ in an Alzheimer's Disease Rat Model
por: Mao, Dan-Dan, et al.
Publicado: (2018) -
Qingxin Kaiqiao Recipe Improves Cognitive Performance, Inhibits Apoptosis, and Reduces Pathological Deposits in APP/PS1 Double Transgenic Mice via the PI3K/Akt Pathway
por: Lin, Shi-Yi, et al.
Publicado: (2020) -
Rongjin Niantong Fang ameliorates cartilage degeneration by regulating the SDF-1/CXCR4-p38MAPK signalling pathway
por: Chen, Jun, et al.
Publicado: (2022) -
Systematic review of long-term Xingnao Kaiqiao needling effcacy in ischemic stroke treatment
por: Yang, Zhi-xin, et al.
Publicado: (2015)